Assem E S, Vickers M R
Immunology. 1974 Aug;27(2):255-69.
The immunological cross-reaction between penicillins and a cephalosporin derivative (cephaloridine CEPR) has been investigated. Cross-allergenicity was studied in twenty-four patients with established penicillin allergy using a variety of tests. Skin tests, quantitative leucocyte challenge (estimating histamine release by allergen) and lymphocyte stimulation (transformation) tests were performed, using CEPR, conjugates of CEPR with human serum albumin (HSA) and bovine gamma-globulin (BGG), benzylpenicillin and benzylpenicilloyl (BPO) conjugates with HSA and BGG. A cross-reaction was clearly established in the majority of patients. The highest percentage of positive results (cross-allergenicity) was obtained in the leucocyte challenge test (80 per cent with CEPR.BGG), followed by the lymphocyte stimulation test (50 per cent with CEPR.BGG), and then the skin test (46 per cent with CEPR.HSA). None of ten non-allergic controls gave a positive result in these tests. Three of the penicillin allergic patients had received cephaloridine, and all three developed allergic reactions. Cross-antigenicity has also been shown by haemagglutination and haemagglutination-inhibition tests on serum from larger groups of penicillin-allergic patients (including the previously mentioned twenty-four patients), and of non-allergic controls, who had anti-BPO antibodies.
对青霉素与一种头孢菌素衍生物(头孢噻啶CEPR)之间的免疫交叉反应进行了研究。使用多种测试方法,对24例已确诊青霉素过敏的患者进行了交叉致敏性研究。使用CEPR、CEPR与人血清白蛋白(HSA)和牛γ球蛋白(BGG)的偶联物、苄青霉素以及苄青霉素酰(BPO)与HSA和BGG的偶联物进行了皮肤试验、定量白细胞激发试验(通过变应原估计组胺释放)和淋巴细胞刺激(转化)试验。在大多数患者中明确证实了交叉反应。白细胞激发试验中获得的阳性结果(交叉致敏性)百分比最高(CEPR.BGG为80%),其次是淋巴细胞刺激试验(CEPR.BGG为50%),然后是皮肤试验(CEPR.HSA为46%)。10名非过敏对照者在这些试验中均未出现阳性结果。3例青霉素过敏患者接受了头孢噻啶治疗,所有3例均出现了过敏反应。对更多组青霉素过敏患者(包括上述24例患者)和有抗BPO抗体的非过敏对照者的血清进行的血凝和血凝抑制试验也显示了交叉抗原性。